← Leaderboards
Robin Ohls
University Of New Mexico
$2,393,894
Attributed
$2,393,894
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,393,894 · 6
By mechanism
M01$2,393,894 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- Robin K Ohls$8,058,323
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchErythropoietinNewborn Human (0-6 Weeks)NeutrophilPremature Infant HumanColony Stimulating FactorRecombinant ProteinsHuman Therapy EvaluationGranulocyteHemoprotein BiosynthesisKidney FunctionKidney MetabolismLeukopeniaLiver MetabolismAnemiaBacterial DiseaseBlood Disorder ChemotherapyBlood /Lymphatic PharmacologyBlood ToxicologyClinical TrialsEmbryo /FetusEmbryo /Fetus HypoxiaGene Expression
Grant awards (20)
EFFECTS OF GRANULOCYTE COLONY STIMULATING FACTOR$282,412
M01 · FY2002 · RR
MOLECULAR &BIOLOGIC BASIS OF ERYTHROPOIETIN REGULATION IN ANEMIA PREMATURITY$282,412
M01 · FY2002 · RR
TRIAL OF RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR$282,412
M01 · FY2002 · RR
ERYTHROPOIETIN PRODUCTION BY THE MID TRIMESTER FETAL KIDNEY$282,412
M01 · FY2002 · RR
EFFECTS OF GRANULOCYTE COLONY STIMULATING FACTOR$282,412
M01 · FY2001 · RR
MOLECULAR &BIOLOGIC BASIS OF ERYTHROPOIETIN REGULATION IN ANEMIA PREMATURITY$282,412
M01 · FY2001 · RR
TRIAL OF RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR$282,412
M01 · FY2001 · RR
ERYTHROPOIETIN PRODUCTION BY THE MID TRIMESTER FETAL KIDNEY$282,412
M01 · FY2001 · RR
EFFECTS OF GRANULOCYTE COLONY STIMULATING FACTOR$22,433
M01 · FY2000 · RR
EFFECTS OF HUMAN RECOMBINANT THROMOPOIETIN (TPO) ON GROWTH OF MEGAKARYOCYTES$22,433
M01 · FY2000 · RR
ERYTHROPOIETIN PRODUCTION BY THE MID TRIMESTER FETAL KIDNEY$22,433
M01 · FY2000 · RR
MOLECULAR &BIOLOGIC BASIS OF ERYTHROPOIETIN REGULATION IN ANEMIA PREMATURITY$22,433
M01 · FY2000 · RR
EFECTS OF ERYTHROPOIETIN (EPO) ON TRANSFUSION REQUIREMENTS OF PRETERM INFANTS$22,433
M01 · FY2000 · RR
TRIAL OF RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR$22,433
M01 · FY2000 · RR
MOLECULAR &BIOLOGIC BASIS OF ERYTHROPOIETIN REGULATION IN ANEMIA PREMATURITY$0
M01 · FY2000 · RR
ERYTHROPOIETIN PRODUCTION BY THE MID TRIMESTER FETAL KIDNEY$0
M01 · FY2000 · RR
EFFECTS OF GRANULOCYTE COLONY STIMULATING FACTOR$0
M01 · FY2000 · RR
EFECTS OF ERYTHROPOIETIN (EPO) ON TRANSFUSION REQUIREMENTS OF PRETERM INFANTS$0
M01 · FY2000 · RR
EFFECTS OF HUMAN RECOMBINANT THROMOPOIETIN (TPO) ON GROWTH OF MEGAKARYOCYTES$0
M01 · FY2000 · RR
TRIAL OF RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR$0
M01 · FY2000 · RR